Abbott India Limited Abbott India Limited

Abbott India Limited

ABBOTINDIA

Classifica tra le azioni #3030
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Prezzo delle azioni
$285.00
Capitalizzazione di mercato
$6.06B
Variazione (1 giorno)
-0.31%
Variazione (1 anno)
-17.08%
Paese
IN
Scambia Abbott India Limited (ABBOTINDIA)

Categoria

Healthcare
Rapporto P/B per Abbott India Limited (ABBOTINDIA)
Rapporto P/B al October 2026 TTM: 11.63
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Abbott India Limited, il rapporto P/B attuale (TTM) è 11.63. Alla fine del 2024, era pari a 15.81.
Storico del rapporto P/B per Abbott India Limited da 2004 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 11.63 -23.56%
2025 15.22 -3.74%
2024 15.81 7.52%
2023 14.70 10.22%
2022 13.34 9.03%
2021 12.24 -9.38%
2020 13.50 74.90%
2019 7.72 12.00%
2018 6.89 -3.10%
2017 7.11 -14.94%
2016 8.36 -6.65%
2015 8.96 89.24%
2014 4.73 -2.69%
2012 4.87 -14.72%
2011 5.71 -2.76%
2010 5.87 44.37%
2009 4.06 -22.69%
2008 5.26 1.18%
2007 5.20 3.57%
2006 5.02 -11.95%
2005 5.70 -13.01%
2004 6.55 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
31.9092 174.26%
US
7.3138 -37.14%
US
-84.6033 -827.17%
US
8.6873 -25.33%
US
8.4776 -27.13%
CH